Does RISDIPLAM Cause Off label use? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Off label use have been filed in association with RISDIPLAM (EVRYSDI). This represents 1.9% of all adverse event reports for RISDIPLAM.
69
Reports of Off label use with RISDIPLAM
1.9%
of all RISDIPLAM reports
2
Deaths
13
Hospitalizations
How Dangerous Is Off label use From RISDIPLAM?
Of the 69 reports, 2 (2.9%) resulted in death, 13 (18.8%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISDIPLAM. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does RISDIPLAM Cause?
No adverse event (324)
Diarrhoea (280)
Asthenia (209)
Pneumonia (182)
Death (165)
Pyrexia (152)
Fatigue (145)
Muscular weakness (125)
Vomiting (121)
Drug ineffective (115)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RISDIPLAM Alternatives Have Lower Off label use Risk?
RISDIPLAM vs RISEDRONATE
RISDIPLAM vs RISEDRONIC ACID
RISDIPLAM vs RISPERDAL
RISDIPLAM vs RISPERDAL CONSTA
RISDIPLAM vs RISPERIDONE